IRWD vs. IMVT

In the year-to-date period, IRWD achieves a -86.48% return, which is significantly lower than IMVT's -40.05% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Ironwood Pharmaceuticals, Inc. (IRWD) and Immunovant, Inc. (IMVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current IRWD Sharpe Ratio is -0.93, which is comparable to the IMVT Sharpe Ratio of -0.85. The chart below compares the historical Sharpe Ratios of IRWD and IMVT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither IRWD nor IMVT has paid dividends to shareholders.

The maximum IRWD drawdown since its inception was -96.79%, roughly equal to the maximum IMVT drawdown of -93.59%. Use the drawdown chart below to compare losses from any high point for IRWD and IMVT.

Ironwood Pharmaceuticals, Inc. (IRWD) has a higher volatility of 32.24% compared to Immunovant, Inc. (IMVT) at 15.20%. This indicates that IRWD's price experiences larger fluctuations and is considered to be riskier than IMVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Ironwood Pharmaceuticals, Inc. and Immunovant, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.